Publications by authors named "Zengjun Li"

Claim this Profile
C
Case Report: CD19 and CD22 CAR-T therapy induced durable complete remission in a patient with refractory plasmablastic lymphoma.
Dan Liu, Haichen Wei, Yanran Hu, Hui Wang, Ping Li, Lijie Xing, Zengjun Li

Front Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Transformation of natural killer-cell large granular lymphocytic leukemia to aggressive natural killer cell leukemia.
Wen Wang, Ke Lu, Lijie Xing, Zengjun Li

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral T-cell lymphoma with central nervous system involvement and elevated interleukin-10 levels in the cerebrospinal fluid: A case report.
Xin Wang, Haichen Wei, Dan Liu, Hui Wang, Zengjun Li, Lijie Xing

Precis Radiat Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic ultrasound with submucosal saline injection improves the accuracy of T1a and T1b staging in superficial esophageal squamous cell carcinoma.
Jianjun Zhang, Ming Chen, Yongsheng Gao, Jinqi Liu, Zengjun Li

Front Med (Lausanne)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifelong impacts of puberty timing on human plasma metabolic profiles: A metabolome-wide Mendelian randomization study.
Zengjun Li, Xuechao Li, Si Fang, Dong Liu, Fei Li

Diabetes Obes Metab· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zanubrutinib plus R-CHOP for the treatment of newly diagnosed double-expressor lymphoma: A phase 2 clinical study.
Xia Yin, Qiang He, Dan Liu, Linna Xie, Hui Wang, Chuanli Zhao, Liang Wang, Lijie Xing, Zengjun Li

Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic risk factors of pneumonia associated with COVID-19 in patients with lymphoma.
Dan Liu, Xia Yin, Hui Wang, Lijie Xing, Ping Li, Linna Xie, Zengjun Li

Front Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China.
Wei Wang, Wei Zhang, Li-Ping Su, Li-Hong Liu, Yu-Huan Gao, Hui Liu, Ai-Chun Liu, Zeng-Jun Li

Ann Hematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study.
Yuqin Song, Zhengming Jin, Zhi-Ming Li, Yanyan Liu, Lanfang Li, Kunyan Li, Dengju Li, Zengjun Li, Yijing Li

Clin Cancer Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fetal genetically determined birth weight plays a causal role in earlier puberty timing: evidence from human genetic studies.
Qinghui Peng, Wenjuan Qiu, Zengjun Li, Jian Zhao, Cairong Zhu

Hum Reprod· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Fever Following Bronchoscopy and Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration.
Ming Chen, Jinqi Liu, Dongyang Wang, Haipeng Wang, Jinna Liang, Zengjun Li

Altern Ther Health Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study.
Yuqin Song, Luis Malpica, Qingqing Cai, Weili Zhao, Keshu Zhou, Yao Liu, Zengjun Li, Liling Zhang, Wenyu Li, Liqun Zou, Fei Li, Lie Lin, Hui Liu

Lancet Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nomogram for predicting the rapid progression of diffuse large B-cell lymphoma established by combining baseline PET/CT total metabolic tumor volume, lesion diffusion, and TP53 mutations.
Cong Liu, Pengyue Shi, Zhenjiang Li, Baosheng Li, Zengjun Li

Cancer Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial.
Tingyu Wang, Xiuhua Sun, Lihua Qiu, Hang Su, Junning Cao, Zhiming Li, Li Zhang, Dengju Li, Junmin Li, Zhifeng Li, Fei Li, Weiliang Zhu, Lihong Liu, Zengjun Li

Clin Cancer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China.
Weiping Liu, Jie Ji, Dehui Zou, Yang Cao, Yajing Xu, Fuling Zhou, Hui Liu, Caixia Li, Hongling Peng, Yao Liu, Zengjun Li, Lin Liu, Lijing Shen, Chuanfang Liu

Bone Marrow Transplant· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosis.
Wei Xu, Shenmiao Yang, Keshu Zhou, Ling Pan, Zengjun Li, Dengju Li, Yiling Yu, William Novotny, Jianyong Li

Leuk Lymphoma· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Successful management of a refractory double-expressor diffuse large B-cell lymphoma patient under the guidance of high-throughput drug sensitivity test.
Lijie Xing, Hui Wang, Dan Liu, Qiang He, Zengjun Li

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular subtypes and a prognostic model for hepatocellular carcinoma based on immune- and immunogenic cell death-related lncRNAs.
Mingang He, Wenchao Gu, Yang Gao, Ying Liu, Jie Liu, Zengjun Li

Front Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review.
Lijie Xing, Qiang He, Linna Xie, Hui Wang, Zengjun Li

Haematologica· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Dimensional Culture Decreases the Angiogenic Ability of Mouse Macrophages.
Haoxin Shi, Dong Li, Qing Shi, Zhenxia Han, Yuwei Tan, Zengjun Li

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An enzyme-activated two-photon ratiometric fluorescent probe with lysosome targetability for imaging β-glucuronidase in colon cancer cells and tissue.
Xianzhe Wei, Juan Li, Xiaofeng Yang, Baoli Dong, Bing Geng, Zengjun Li

Anal Chim Acta· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer.
Ling Wei, Jujie Sun, Nasha Zhang, Yue Shen, Teng Wang, Zengjun Li

Front Cell Dev Biol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 clinical trial of the PI3Kδ inhibitor YY-20394 in patients with B-cell hematological malignancies.
Bo Jiang, Junyuan Qi, Yuqin Song, Zengjun Li, Meifeng Tu, Lingyan Ping, Zongliang Liu

J Hematol Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylaxis of neutropenia with mecapegfilgrastim in patients with non-myeloid malignancies: a real-world study.
Jun Ma, Huiqiang Huang, Peifen Fu, Nong Xu, Chenyu Mao, Yongqing Li, Liang Chen, Ningling Zhang, Zengjun Li, Lihua Song

Ann Transl Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study.
Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hui Liu, Aichun Liu, Zengjun Li

Cancer Biol Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis